Description

Retatrutyd 10 mg

Retatrutide is an innovative peptide with significant applications in advanced metabolic research. This triple-action compound targets GLP-1, GIP, and glucagon receptors, making it a cutting-edge focus for studying complex metabolic processes.

Key Features:
• Triple Receptor Agonist – Simultaneously activates GLP-1, GIP, and glucagon receptors
• Metabolic Insight – Explores mechanisms related to glucose regulation, lipid metabolism, and energy balance
• Research Only – For qualified professionals investigating advanced peptide pathways

Handling Notes:
Ensure both the peptide and bacteriostatic water are at room temperature before reconstitution to support proper dissolution and compound stability.
Bacteriostatic water sold separately.

Patent Status & Availability

Retatrutide is a patented investigational compound currently under development for therapeutic research. This product is not affiliated with or sourced from any brand holder, and is supplied strictly for independent research purposes only, in accordance with international standards for non-commercial scientific use.

⚠️ Research Use Only Disclaimer

All products featured on this site are intended solely for research purposes and are de 12,99 € à 49,99 € Délai de livraison estimé : 2 à 7 jours, selon la destination.

By purchasing, the buyer accepts full responsibility for the safe handling, storage, and use of the compound, and confirms that they are a qualified professional conducting legitimate scientific work. Neither the distributor, manufacturer, nor seller shall be held liable for any misuse or outcome related to the use of this research material.

By completing your order, you confirm that:

• You are over 18

• You understand and accept our [Terms & Conditions]

• You agree to handle all products in compliance with all applicable laws and safety standards.

   

  *Research use only*—not for human consumption. Preclinical studies show [effects], but human data pending.